IMBA - INSTITUT FÜR MOLEKULARE BIOTECHNOLOGIE GMBH
发明人:
PENNINGER JOSEF,SCHRAMEK DANIEL
申请号：
NZ60820711
公开号：
NZ608207A
申请日:
2011.09.22
申请国别(地区):
NZ
年份:
2014
代理人:
摘要：
Disclosed is the use of a RANKL inhibitor for the manufacture of a medicament for preventing a primary breast or mammary cancer in a subject, wherein the medicament is intended to be administered in a therapeutically effective amount to said subject, wherein said inhibitor inhibits binding of RANKL to RANK.
